Low-level expression of MARCH8 was observed in most of the lung cancer samples (49 of 60, 81.67%), whereas a much lower percentage of normal tissue showed low expression of MARCH8 (18 of 60, 30%). This evidence concerns the gene MARCHF8 and lung carcinoma.